These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38244527)

  • 1. The glymphatic system as a potential biomarker and therapeutic target in secondary progressive multiple sclerosis.
    Tomizawa Y; Hagiwara A; Hoshino Y; Nakaya M; Kamagata K; Cossu D; Yokoyama K; Aoki S; Hattori N
    Mult Scler Relat Disord; 2024 Mar; 83():105437. PubMed ID: 38244527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enlarged choroid plexus in relapsing-remitting multiple sclerosis may lead to brain structural changes through the glymphatic impairment.
    Xie Y; Zhu H; Yao Y; Liu C; Wu S; Zhang Y; Zhu W
    Mult Scler Relat Disord; 2024 May; 85():105550. PubMed ID: 38493535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Carotenuto A; Cacciaguerra L; Pagani E; Preziosa P; Filippi M; Rocca MA
    Brain; 2022 Aug; 145(8):2785-2795. PubMed ID: 34919648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of glymphatic system alterations in multiple sclerosis and neuromyelitis optica spectrum disorder using MRI indices from diffusion tensor imaging.
    Kim M; Hwang I; Park JH; Chung JW; Kim SM; Kim JH; Choi KS
    Hum Brain Mapp; 2024 Apr; 45(5):e26680. PubMed ID: 38590180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
    Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
    Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glymphatic dysfunction in multiple sclerosis and its association with disease pathology and disability.
    Bayoumi A; Hasan KM; Thomas JA; Yazdani A; Lincoln JA
    Mult Scler; 2024 Nov; 30(13):1609-1619. PubMed ID: 39344166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral glymphatic dysfunction and its association with disease duration in unilateral temporal lobe epilepsy patients with hippocampal sclerosis.
    Xie F; Zhou C; Jin H; Xing W; Wang D
    Epilepsy Behav; 2024 Jun; 155():109777. PubMed ID: 38640726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis.
    Margoni M; Pagani E; Meani A; Preziosa P; Mistri D; Gueye M; Moiola L; Filippi M; Rocca MA
    Ann Neurol; 2024 Jun; 95(6):1080-1092. PubMed ID: 38481063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting-state fMRI network efficiency as a mediator in the relationship between the glymphatic system and cognitive function in obstructive sleep apnea hypopnea syndrome: Insights from a DTI-ALPS investigation.
    Xiong Z; Bai M; Wang Z; Wang R; Tian C; Wang L; Nie L; Zeng X
    Sleep Med; 2024 Jul; 119():250-257. PubMed ID: 38704873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glymphatic system dysfunction in temporal lobe epilepsy patients with hippocampal sclerosis.
    Lee DA; Park BS; Ko J; Park SH; Lee YJ; Kim IH; Park JH; Park KM
    Epilepsia Open; 2022 Jun; 7(2):306-314. PubMed ID: 35305294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis.
    El Ayoubi NK; Sabbagh HM; Bou Rjeily N; Hannoun S; Khoury SJ
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36229190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glymphatic system impairment in patients with status epilepticus.
    Lee DA; Lee J; Park KM
    Neuroradiology; 2022 Dec; 64(12):2335-2342. PubMed ID: 35835880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients.
    Liang T; Chang F; Huang Z; Peng D; Zhou X; Liu W
    Br J Radiol; 2023 Jun; 96(1146):20220315. PubMed ID: 37066824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study.
    Manchon E; Laplaud D; Vukusic S; Labauge P; Moreau T; Kobelt G; Grouin JM; Lotz M; Pau D; Christine LF
    Mult Scler Relat Disord; 2022 Dec; 68():104109. PubMed ID: 36007299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glymphatic System Dysfunction Underlying Schizophrenia Is Associated With Cognitive Impairment.
    Tu Y; Fang Y; Li G; Xiong F; Gao F
    Schizophr Bull; 2024 Aug; 50(5):1223-1231. PubMed ID: 38581275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space in presbycusis.
    Xu K; Zhang J; Xing C; Xu X; Yin X; Wu Y; Chen X; Chen YC
    CNS Neurosci Ther; 2024 Mar; 30(3):e14458. PubMed ID: 37680170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glymphatic system evaluation using diffusion tensor imaging in patients with traumatic brain injury.
    Park JH; Bae YJ; Kim JS; Jung WS; Choi JW; Roh TH; You N; Kim SH; Han M
    Neuroradiology; 2023 Mar; 65(3):551-557. PubMed ID: 36274107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glymphatic system dysfunction in restless legs syndrome: evidenced by diffusion tensor imaging along the perivascular space.
    Park KM; Kim KT; Lee DA; Motamedi GK; Cho YW
    Sleep; 2023 Nov; 46(11):. PubMed ID: 37702251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome.
    Andica C; Kamagata K; Takabayashi K; Kikuta J; Kaga H; Someya Y; Tamura Y; Kawamori R; Watada H; Taoka T; Naganawa S; Aoki S
    Neurobiol Dis; 2023 Feb; 177():105990. PubMed ID: 36621631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.